Voltage-gated sodium channel blocker pipeline beyond pain

While the majority of Nav-targeted drug development is focused on pain, at least six programs are targeting the voltage-gated sodium channels for other indications, with most of the activity in seizures.

For seizures, the rationale for a surgical strike against select Nav subtypes is a cleaner side effect profile...